Literature DB >> 21502081

Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection.

Meng Ling Moi1, Chang-Kweng Lim, Akira Kotaki, Tomohiko Takasaki, Ichiro Kurane.   

Abstract

It has been reported that levels of viremia reflect the severity of illness in dengue virus infection. We assessed the levels of viremia in patients with primary and secondary infections, using 2 cell lines: FcγR-expressing BHK cells and FcγR-negative cells. In primary infection, virus titers were at similar levels between FcγR-expressing and FcγR-negative cells. In secondary infection, however, virus titers were ∼10 times higher in FcγR-expressing cells on days 1-6 when compared with FcγR-negative cells, indicating discrepancy in viremia titers between FcγR-expressing and FcγR-negative cells. The results suggest that dengue virus-antibody complexes with infectious capacity exist in patients with secondary infection, and these immune complexes can be detected by using FcγR-expressing cells. As it has been reported that principal target cells of dengue virus infection are FcγR-positive, monocyte/macrophage lineage cells, virus titers determined using FcγR-expressing cells may better reflect the actual viremic conditions in vivo.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502081      PMCID: PMC3080903          DOI: 10.1093/infdis/jir053

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Virus isolation as one of the diagnostic methods for dengue virus infection.

Authors:  Ken-Ichiro Yamada; Tomohiko Takasaki; Masaru Nawa; Ichiro Kurane
Journal:  J Clin Virol       Date:  2002-04       Impact factor: 3.168

2.  Sensitivity of Aedes albopictus C6/36 cells line for the detection and infectivity titration of dengue virus.

Authors:  I Zamree; N Drakes; A Rohani; H L Lee
Journal:  Trop Biomed       Date:  2005-12       Impact factor: 0.623

Review 3.  Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses.

Authors:  John T Roehrig; Joachim Hombach; Alan D T Barrett
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

4.  Circulating immune complexes in serum from patients with dengue haemorrhagic fever.

Authors:  W Ruangjirachuporn; S Boonpucknavig; S Nimmanitya
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

5.  Dengue virus isolation by antibody-dependent enhancement of infectivity in macrophages.

Authors:  M J Cardosa
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

6.  Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.

Authors:  D M Morens; S B Halstead; P M Repik; R Putvatana; N Raybourne
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

7.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

8.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.

Authors:  Adriana O Guilarde; Marilia D Turchi; Joao Bosco Siqueira; Valeria C R Feres; Benigno Rocha; Jose E Levi; Vanda A U F Souza; Lucy Santos Vilas Boas; Claudio S Pannuti; Celina M T Martelli
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

10.  Clinical, epidemiological and virological features of Dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever.

Authors:  Khoa T D Thai; Hoang Lan Phuong; Tran Thi Thanh Nga; Phan Trong Giao; Le Quoc Hung; Nguyen Van Nam; Tran Quang Binh; Cameron Simmons; Jeremy Farrar; Tran Thinh Hien; H Rogier van Doorn; Menno D de Jong; Peter J de Vries
Journal:  J Infect       Date:  2010-01-18       Impact factor: 6.072

View more
  17 in total

1.  Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Authors:  Satoru Watanabe; Kitti Wing Ki Chan; Jiaqi Wang; Laura Rivino; Shee-Mei Lok; Subhash G Vasudevan
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Authors:  Syo Nakajima; Koichi Watashi; Hirofumi Ohashi; Shinji Kamisuki; Jesus Izaguirre-Carbonell; Andrew Tae-Jun Kwon; Harukazu Suzuki; Michiyo Kataoka; Senko Tsukuda; Maiko Okada; Meng Ling Moi; Toshifumi Takeuchi; Minetaro Arita; Ryosuke Suzuki; Hideki Aizaki; Takanobu Kato; Tadaki Suzuki; Hideki Hasegawa; Tomohiko Takasaki; Fumio Sugawara; Takaji Wakita
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.

Authors:  Meng Ling Moi; Yasushi Ami; Kenji Shirai; Chang-Kweng Lim; Yuriko Suzaki; Yuka Saito; Kazutaka Kitaura; Masayuki Saijo; Ryuji Suzuki; Ichiro Kurane; Tomohiko Takasaki
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

4.  Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Gina C Donofrio; Mary A Marovich
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

5.  Clinical, virological and epidemiological characterization of dengue outbreak in Myanmar, 2015.

Authors:  A K Kyaw; M M Ngwe Tun; M L Moi; T Nabeshima; K T Soe; S M Thwe; A A Myint; K T T Maung; W Aung; D Hayasaka; C C Buerano; K Z Thant; K Morita
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

6.  Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.

Authors:  Meng Ling Moi; Chang-Kweng Lim; Kaw Bing Chua; Tomohiko Takasaki; Ichiro Kurane
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

7.  Autochthonous dengue fever, Tokyo, Japan, 2014.

Authors:  Satoshi Kutsuna; Yasuyuki Kato; Meng Ling Moi; Akira Kotaki; Masayuki Ota; Koh Shinohara; Tetsuro Kobayashi; Kei Yamamoto; Yoshihiro Fujiya; Momoko Mawatari; Tastuya Sato; Junwa Kunimatsu; Nozomi Takeshita; Kayoko Hayakawa; Shuzo Kanagawa; Tomohiko Takasaki; Norio Ohmagari
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

8.  Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019.

Authors:  Aung Min Soe; Mya Myat Ngwe Tun; Takeshi Nabeshima; Theingi Win Myat; Moh Moh Htun; Htin Lin; Nang Sarm Hom; Shingo Inoue; Khine Mya Nwe; Lynn Pa Pa Aye; Mizuki Fukuta; Kyaw Zin Thant; Futoshi Hasebe; Kouichi Morita; Sujan Shresta; Hlaing Myat Thu; Meng Ling Moi
Journal:  Viruses       Date:  2021-06-16       Impact factor: 5.048

9.  Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity.

Authors:  Peifang Sun; Josefina García; Guillermo Comach; Maryanne T Vahey; Zhining Wang; Brett M Forshey; Amy C Morrison; Gloria Sierra; Isabel Bazan; Claudio Rocha; Stalin Vilcarromero; Patrick J Blair; Thomas W Scott; Daria E Camacho; Christian F Ockenhouse; Eric S Halsey; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.

Authors:  Panjaporn Chaichana; Tamaki Okabayashi; Orapim Puiprom; Mikiko Sasayama; Tadahiro Sasaki; Akifumi Yamashita; Pongrama Ramasoota; Takeshi Kurosu; Kazuyoshi Ikuta
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.